• Product nameAnti-TNXB antibody
    See all TNXB primary antibodies
  • Description
    Rabbit polyclonal to TNXB
  • Tested applicationsSuitable for: IHC-Pmore details
  • Species reactivity
    Reacts with: Human
    Predicted to work with: Mouse
  • Immunogen

    A synthesized peptide derived from an internal region of Human TNXB.

  • Positive control
    • Human breast carcinoma tissue.


  • FormLiquid
  • Storage instructionsShipped at 4°C. Store at -20°C. Stable for 12 months at -20°C.
  • Storage bufferpH: 7.40
    Preservative: 0.02% Sodium azide
    Constituents: 50% Glycerol, PBS, 0.88% Sodium chloride
  • Concentration information loading...
  • PurityImmunogen affinity purified
  • ClonalityPolyclonal
  • IsotypeIgG
  • Research areas


Our Abpromise guarantee covers the use of ab111270 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
IHC-P 1/50 - 1/100. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.


  • FunctionAppears to mediate interactions between cells and the extracellular matrix. Substrate-adhesion molecule that appears to inhibit cell migration. Accelerates collagen fibril formation. May play a role in supporting the growth of epithelial tumors.
  • Tissue specificityHighly expressed in fetal adrenal, in fetal testis, fetal smooth, striated and cardiac muscle. Isoform XB-short is only expressed in the adrenal gland.
  • Involvement in diseaseTenascin-X deficiency (TNXD) [MIM:606408]: TNXD leads to an Ehlers-Danlos-like syndrome characterized by hyperextensible skin, hypermobile joints, and tissue fragility. Tenascin-X-deficient patients, however, lack atrophic scars, a major diagnostic criteria for classic Ehlers-Danlos. Delayed wound healing, which is also common in classic EDS, is only present in a subset of patients. Note=The disease is caused by mutations affecting the gene represented in this entry.
  • Sequence similaritiesBelongs to the tenascin family.
    Contains 19 EGF-like domains.
    Contains 1 fibrinogen C-terminal domain.
    Contains 32 fibronectin type-III domains.
  • Developmental stageExpression levels are lower in adults than in children.
  • Cellular localizationSecreted > extracellular space > extracellular matrix.
  • Information by UniProt
  • Database links
  • Alternative names
    • EDS3 antibody
    • Ehlers Danlos like syndrome antibody
    • Growth inhibiting protein 45 antibody
    • Hexabrachion like protein antibody
    • Hexabrachion-like protein antibody
    • HXBL antibody
    • NXB2 antibody
    • Tenascin X precursor antibody
    • Tenascin XB antibody
    • Tenascin XB1 antibody
    • Tenascin XB2 antibody
    • Tenascin-X antibody
    • TENX antibody
    • TENX_HUMAN antibody
    • TN X antibody
    • TN-X antibody
    • TNX antibody
    • TNXB antibody
    • TNXB1 antibody
    • TNXB2 antibody
    • TNXBS antibody
    • VUR8 antibody
    • XB antibody
    • XBS antibody
    see all

Anti-TNXB antibody images

  • Immunohistochemistry analysis of paraffin-embedded Human breast carcinoma tissue, using 1/50 ab111270. The picture on the right is treated with the synthesized peptide

References for Anti-TNXB antibody (ab111270)

ab111270 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab111270.
Please use the links above to contact us or submit feedback about this product.